Community Health Systems (CYH) director receives 52,023 new RSUs

Rhea-AI Filing Summary

LOPEZ FAWN D reported acquisition or exercise transactions in this Form 4 filing.

COMMUNITY HEALTH SYSTEMS INC director Fawn D. Lopez received a grant of 52,023 restricted stock units on March 1, 2026. The award was granted at no cash cost and increased her directly held restricted stock units to 122,519 in total.

These restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the grant date. Upon vesting, they are scheduled to be settled in shares of common stock on a one-for-one basis, subject to prior deferral elections that can delay settlement until she ceases to be a director or until specified future dates.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider LOPEZ FAWN D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	52,023	$0.00	--
holding	Restricted Stock Units	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 52,023 shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

1. These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis. These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOPEZ FAWN D

(Last) (First) (Middle)

4000 MERIDIAN BOULEVARD

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COMMUNITY HEALTH SYSTEMS INC [ CYH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	03/01/2026		A		52,023		(1)	(1)	Common Stock	52,023	$0	52,023	D
Restricted Stock Units	$0							(2)	(2)	Common Stock	122,519		122,519	D

Explanation of Responses:

1. These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of the grant. Upon vesting, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis.

2. These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, these restricted stock units will be settled in shares of the Issuer's common stock on a one-for-one basis upon the Reporting Person's cessation as a director or upon a date or dates previously specified by the Reporting Person.

	Christopher G. Cobb, Attorney in Fact for Fawn D. Lopez	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CYH director Fawn D. Lopez report on this Form 4?

Fawn D. Lopez reported receiving a grant of 52,023 restricted stock units on March 1, 2026. This equity award increased her directly held restricted stock units to 122,519, reflecting stock-based compensation rather than an open-market share purchase or sale.

How many restricted stock units does CYH director Fawn D. Lopez now hold?

After the March 1, 2026 award, Fawn D. Lopez directly holds 122,519 restricted stock units. These units represent a right to receive an equal number of Community Health Systems common shares in the future, subject to the vesting and settlement conditions described in the Form 4 footnotes.

What is the vesting schedule for Fawn D. Lopez’s new CYH restricted stock units?

The 52,023 restricted stock units granted to Fawn D. Lopez vest in one-third increments on the first, second, and third anniversaries of the March 1, 2026 grant date. This three-year vesting structure ties the equity award to continued board service over time.

How will Fawn D. Lopez’s CYH restricted stock units be settled when they vest?

Upon vesting, the restricted stock units are scheduled to be settled in Community Health Systems common stock on a one-for-one basis. Some units are subject to prior deferral elections, so settlement may occur when she ceases as a director or on specified future dates.

Does the Form 4 show any Community Health Systems common stock directly held by Fawn D. Lopez?

The Form 4 indicates that Fawn D. Lopez directly holds zero shares of Community Health Systems common stock after the reported transactions. Her reported equity exposure is entirely through restricted stock units, which convert into common shares only upon future settlement.